Phosphodiesterase type-5 inhibitor use in type 2 diabetes...

Artery Research 2014 / 12 Vol. 8; Iss. 4

Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all cause mortality

Anderson, S., Hutchings, D., Kwok, C., Trafford, A., Heald, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Artery Research
DOI:
10.1016/j.artres.2014.09.162
Date:
December, 2014
File:
PDF, 48 KB
english, 2014
Conversion to is in progress
Conversion to is failed